These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32058313)

  • 1. Cervical cancer screening in the Canadian armed forces: An estimation of screening participation rates using the CF-HERO surveillance system.
    Naicker K; Hawes R
    Cancer Epidemiol; 2020 Apr; 65():101670. PubMed ID: 32058313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening for survivors diagnosed with cancer before age 25.
    Tseng OL; Spinelli JJ; Dawes M; McBride ML
    J Cancer Surviv; 2017 Jun; 11(3):410-419. PubMed ID: 28127670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
    Tavasoli SM; Kane E; Chiarelli AM; Kupets R
    Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
    J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.
    Dickinson JA; Stankiewicz A; Popadiuk C; Pogany L; Onysko J; Miller AB
    BMC Public Health; 2012 Nov; 12():992. PubMed ID: 23158654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Immigrant Status Associated With Cervical Cancer Screening Among Women in Canada? Results From a Cross-Sectional Study.
    Bacal V; Blinder H; Momoli F; Wu KY; McFaul S
    J Obstet Gynaecol Can; 2019 Jun; 41(6):824-831.e1. PubMed ID: 30361160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
    MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
    J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
    Coldman A; van Niekerk D; Smith L; Ogilvie G
    J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
    JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
    Sriplung H; Singkham P; Iamsirithaworn S; Jiraphongsa C; Bilheem S
    Asian Pac J Cancer Prev; 2014; 15(22):10003-8. PubMed ID: 25520060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of papanicolaou (Pap) test rates across Ontario and factors associated with cervical screening.
    Fehringer G; Howlett R; Cotterchio M; Klar N; Majpruz-Moat V; Mai V
    Can J Public Health; 2005; 96(2):140-4. PubMed ID: 15850036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population.
    Guilcher SJ; Newman A; Jaglal SB
    J Womens Health (Larchmt); 2010 Jan; 19(1):57-63. PubMed ID: 20088659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
    MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
    J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.